Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): a risk-benefit analysis.
J Thorac Oncol
; 2(5): 397-401, 2007 May.
Article
en En
| MEDLINE
| ID: mdl-17473654
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Carcinoma de Pulmón de Células no Pequeñas
/
Taxoides
/
Glutamatos
/
Guanina
/
Neoplasias Pulmonares
/
Antineoplásicos
Tipo de estudio:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Thorac Oncol
Año:
2007
Tipo del documento:
Article
País de afiliación:
Francia